The ongoing legal battle over Maharashtra's Certificate Course in Modern Pharmacology (CCMP) has taken an intriguing turn with the National Commission for Homoeopathy's (NCH) recent clarification. This development brings the spotlight back to the contentious issue of whether CCMP-qualified homoeopaths can be registered with the Maharashtra Medical Council (MMC).
The NCH's clarification, issued last week, delves into the intricate web of professional conduct regulations. It highlights a general restriction that homoeopathic practitioners cannot practice any other system of medicine, yet it also introduces a specific exception. This exception allows practitioners to work under government programs, provided they have undergone training or courses recognized by the competent authority.
This nuanced stance raises important questions about the scope of CCMP and its potential impact on homoeopathic practitioners. The commission's clarification is particularly significant in the context of Maharashtra's CCMP, which has sparked controversy and protests from modern medicine doctors.
At the heart of the matter lies the idea of 'bridge courses' in India, aiming to provide additional training to practitioners from other systems for primary healthcare in underserved areas. However, this concept has faced opposition from modern medicine doctors, who argue that prescribing medicines requires a holistic approach, including diagnosis, clinical training, and managing complications.
Maharashtra's CCMP, a state-specific adaptation, allows homoeopathic doctors with a Bachelor of Homoeopathic Medicine and Surgery (BHMS) degree to undergo additional training in modern pharmacology. The controversy escalated when the state began registering these practitioners with the MMC, leading to a legal dispute that has been pending since 2014.
Dr. Ravi Wankhedkar, a former national president of the Indian Medical Association (IMA), suggests that the NCH's clarification aims to guide the court in understanding the regulatory position on CCMP. He emphasizes the distinction between limited permission to prescribe specific medicines and being placed on the statutory register governing modern-medicine practitioners.
The IMA and Maharashtra Medical Council members initiated the legal challenge in 2014, and the Supreme Court later urged the High Court to expedite the matter. However, the issue remains unresolved, leaving the future of CCMP and its implications for homoeopathic and modern medicine practitioners in a state of uncertainty.
This complex scenario underscores the need for a comprehensive understanding of the regulatory landscape and the potential impact on healthcare delivery in Maharashtra. As the legal battle continues, the NCH's clarification adds a layer of complexity, leaving many questions unanswered and the outcome of the case hanging in the balance.
